Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.
Sensydia has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2026.
Sensydia's investors include Colle Capital Partners, Frontier Venture Capital, National Heart, Lung and Blood Institute, Orlando Health Ventures.
Sensydia is headquartered in Valencia, United States.
Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.
Sensydia is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sensydia — Funding & Investors." VCBacked, October 13, 2026, https://www.vcbacked.co/company/sensydia. Accessed November 14, 2026.
VCBacked. (2026). Sensydia — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/sensydia
{{cite web |title=Sensydia — Funding & Investors |url=https://www.vcbacked.co/company/sensydia |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sensydia? Request a listing update